期刊文献+

药源性帕金森综合征临床特征及诊断进展 被引量:3

Advances in diagnosis and clinical features of drug-induced Parkinsonism
原文传递
导出
摘要 药源性帕金森综合征(DIP)是由抗精神病药、钙离子通道拮抗剂、胃肠道动力药和抗癫痫药等所致的常见并发症,是中老年人最常见的继发性帕金森综合征。各种药物所致的DIP在临床上并不少见,然而却易漏诊漏治。停药是主要的治疗方法,如无法停药则应换用风险较低的药物。文中就DIP的定义、危险因素、发病机制、临床特征、诊治和预后相关进展做一综述,以提高对这种可防可治的医源性疾病的认识。 Drug-induced Parkinsonism(DIP)is a common complication of antipsychotic drugs,calcium channel antagonists,gastrointestinal prokinetic drugs,and antiepileptic drugs and the most common secondary Parkinsonism in the elderly.DIP caused by various drugs is not uncommon in clinic.However,it is easy to omit diagnosis and treatment.Withdrawal of offending drugs is the main treatment and lower risk drugs should be switched if the drug in use cannot be discontinued.The advances in definition,risk factors,pathogenesis,clinical features,diagnosis and treatment,and prognosis of DIP are reviewed in this paper,in order to improve cognition for this curable iatrogenic disease in clinical practice.
作者 孙玲 贺诗佳 王晓明 张树山 Sun Ling;He Shijia;Wang Xiaoming;Zhang Shushan(Department of Neurology,the Affiliated Hospital of North Sichuan Medical College,Nanchong,Sichuan 637000,China)
出处 《中华神经科杂志》 CAS CSCD 北大核心 2021年第3期276-280,共5页 Chinese Journal of Neurology
基金 川北医学院附属医院科研发展计划项目重点项目(2019ZD014)。
关键词 药源性帕金森综合征 多巴胺受体阻滞剂 临床特征 综述 Drug-induced Parkinsonism Dopamine receptor blockers Clinical feature Review
  • 相关文献

参考文献1

二级参考文献12

  • 1吴春泽,郭沈昌.实用神经精神科药物手册[M].北京:人民军医出版社,2004:55,70.
  • 2Mena MA,Garcia de Yebenes MJ,Tabernero C,et al.Effects of calcium antagonists on the dopamine system[J]. Clin Neurophar macol,1995,18(5):410-426.
  • 3Jimenez-Jimenez FJ,Orti-Pareja M,Ayuso-Peralta L,et al.Druginduced parkinsonism in a movement disorders unit:A four-year survey[J]. Parkinsonism Relat Disord,1996,2(3):145-149.
  • 4Seijo Martinez M,Castro del Rio M,Uez Alvarez J,et al.Prevalence of parkinsonism and Parkinson's disease in the Arosa Island(Spain):a community-based door-to-door survey[J]. J Neurol Sci,2011,304(l-2):49-54.
  • 5Susatia F,Fernandez HH.Drug-induced parkinsonism[J]. Curr Treat Options Neurol,2009,ll(3):162-169.
  • 6Remington G,Mamo D,Labelle A,et al.A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone[J]. Am J Psychiatry,2006,163(3):396-401.
  • 7Bondon-Guitton E,Perez-Lloret S,Bagheri H,et al.Drug-induced parkinsonism:a review of 17 years'experience in a regional pharmacovigilance center in France[J]. Mov Disord,2011,26(12):2226-2231.
  • 8Garcia-Ruiz PJ,Garcia de Ye'benes J.Parkinsonism associated with calcium channel blockers:a prospective follow-up study[J]. Clin Neuropharmacol,1992,15(1):19-26.
  • 9Lopez-Sendon JL,Mena MA,de Yebenes JG.Drug-induced parkinsonism in the elderly:incidence,management and prevention[J]. Drugs Aging,2012,29(2):105-118.
  • 10Rodnitzky RL.Drug-induced movement disorders[J]. Clin Neuro pharmacol,2002,25(3):146.

共引文献1

同被引文献26

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部